TCM
RNLX

Traynor Capital Management’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Traynor Capital Management’s Portfolio RNLX Stock Details RNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-61,750
Closed -$12.9K – 337
2024
Q3 		$12.9K Buy
61,750
+1,750
+3% +$559 ﹤0.01% 274
2024
Q2 		$13.9K Buy
+60,000
New +$35.8K ﹤0.01% 272

Other funds holding RNLX

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
IIC
Ironwood Investment Counsel Scottsdale, Arizona $694M AUM 16.84% 1-Year Est. Return

Traynor Capital Management's RNLX Position: Q4 2024 in Review

Traynor Capital Management sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2024, closing a stake of 61,750 shares — an estimated $12.9K sold.

Traynor Capital Management first reported a position in RNLX in Q2 2024 and held it in 2 quarters. The position peaked at $13.9K in Q2 2024. 3 funds tracked by Wall St. Rank hold RNLX as of Q4 2024.

  • Traynor Capital Management reported no remaining Renalytix plc American Depositary Shares position as of Q4 2024 after selling out during the quarter.
  • Traynor Capital Management sold 61,750 Renalytix plc American Depositary Shares shares in Q4 2024, an estimated $12.9K.
  • Traynor Capital Management first reported a position in Renalytix plc American Depositary Shares in Q2 2024 and held it in 2 quarters.
  • Traynor Capital Management's Renalytix plc American Depositary Shares position peaked at $13.9K in Q2 2024.
  • 3 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2024.

Based on Traynor Capital Management's 13F filing for Q4 2024, filed 17 Jan 2025.